Preventative maintenance contract on vitrocell 24/48 exposure module system (ENDS) electronic nicotine delivery system
Active Purchase Order Awarded Last action
- Contract number
- 75F40125P00134
- Awardee
-
Vitrocell Systems GMBH UEI JTVVCFE2W7H7 Part of Pieter Van Weenen & CO. GMBH
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $56,523
Award facts
- Opportunity
-
- Preventative Maintenance Contract on a Vitrocell 24/48 Exposure Modules Solicitation · 75F40125Q129403 · Posted Jul 1, 2025
- Contract value 36% obligated
-
- $56,523.00 Current, with exercised options
- $158,220.00 Potential, with all options
- Completion date 26% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Jefferson, AR 72079, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $29,283 | |
| Original award | $27,240 |
About this award
The Food and Drug Administration has awarded a $158,220 firm fixed-price purchase order to Vitrocell Systems GMBH, a German-based manufacturer of advanced laboratory equipment, for preventative maintenance services on a Vitrocell 24/48 exposure module system located in Jefferson, Arkansas. The contract, awarded on July 22, 2025, with an ultimate completion date of July 27, 2030, supports the FDA's National Center for Toxicological Research and its collaborative work with the Center for Tobacco Products to conduct toxicity evaluations of whole smoke from tobacco products. The maintenance scope includes annual on-site preventive maintenance visits by certified service engineers, unlimited software and firmware updates, technical support, and all associated labor, travel, and parts costs in accordance with Original Equipment Manufacturer specifications.
This award was issued through full and open competition with no set-aside designation, following a solicitation posted July 1, 2025. Vitrocell Systems GMBH, a subsidiary of parent company Pieter Van Weenen & CO. GMBH, brings established expertise in supporting FDA research infrastructure, with prior contract awards totaling over $950,000 for specialized laboratory equipment and maintenance services. The contract structure includes one base year with four option years, reflecting the FDA's ongoing need to maintain critical equipment supporting its tobacco product regulatory evaluation mission.
Quick answers
Who was awarded contract 75F40125P00134?
75F40125P00134 was awarded to Vitrocell Systems GMBH by Food and Drug Administration (Department of Health and Human Services) on July 22, 2025.
How much is contract 75F40125P00134 worth?
The government has obligated $56,523 on 75F40125P00134. Its potential value, with all options, is $158,220.
Was contract 75F40125P00134 competed?
The extent of competition for 75F40125P00134 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award